ARCHIVES

Velcade Addition Can Improve Graft-Versus-Host Outcomes

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

DCT Counselors Ponder Coordination, New Opportunities

December 12, 1975

Reports of SPOREs cut Premature, Broder Says, Wait for Peer Review

March 13, 1992

Three Organizations Publish Guideline For Biomarker Testing for Targeted Therapies

April 26, 2013

Chromosomal Abnormalities Predict Long Median Survival

January 27, 2012

Freireich’s Seven Laws To Protect Against Obstacles To Clinical Research

May 14, 1976

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

August 26, 2005